Oxford Biomedica plc Company Profile Complimentary D&B Business Overview on over 38 million companies with Free Registration!

Oxford Biomedica plc

Magdalen Centre
Robert Robinson Avenue
The Oxford Science Park, Oxford. OX4
United Kingdom
URL: http://www.oxfordbiomedica.co.uk/
Primary Symbols & Exchanges:
OXB - London
- OTC Bulletin Board
Primary Industry:
Biotechnology
SIC Industry Code:
NAICS Industry Code:
Thomson Financial Business Description:
The Group's principal activity is researching and developing genebased medicines and therapeutic vaccines based on a broad technology platform. The Group's development pipeline comprises four products in clinical development and a late-stage preclinical candidate. The lead product is TroVax, a therapeutic vaccine that has potential application in a range of tumour types. The product is designed to stimulate a specific anti-cancer immune response against a protein called 5T4. The Group's other products are Hi-8 MEL, MetXia, ProSavin and RetinoStat. The Group operates in the United Kingdom and the United States of America.
Alacra Alerts: Oxford Biomedica plc RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on Oxford Biomedica plc

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:






Search for more premium content on Oxford Biomedica plc
  about us contact us public company index private company index pcan widget your privacy rights terms & conditions